Literature DB >> 17348290

Murine gammaherpesvirus 68: a model for the study of Epstein-Barr virus infections and related diseases.

Melissa Olivadoti1, Linda A Toth, Jason Weinberg, Mark R Opp.   

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human gammaherpesvirus (GHV) that causes acute infection and establishes life-long latency. EBV is associated with the development of B-cell lymphoproliferative disorders, several malignant cancers, the syndrome of infectious mononucleosis, and chronic interstitial lung disease. Although the molecular biology of EBV has been characterized extensively, the associated disease conditions and their pathogenesis are difficult to study in human populations because of variation in human environments and genetics, the well-documented effect of stressors on pathogenesis, and the chronic and latent properties of the virus. GHV are highly species-specific, and suitable animal models for EBV are not available. However, in 1980, a murine gammaherpesvirus (MuGHV, also known as MHV68 and gammaHV68) was identified as a natural pathogen of bank voles and wood mice. Experimental MuGHV infections in laboratory mice share many features of EBV infections in humans, including facets of the clinical human syndrome known as infectious mononucleosis. These features make MuGHV a valuable experimental model for studying the pathophysiology of a GHV in a natural host.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348290

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  24 in total

1.  Sleep and fatigue in mice infected with murine gammaherpesvirus 68.

Authors:  Melissa D Olivadoti; Jason B Weinberg; Linda A Toth; Mark R Opp
Journal:  Brain Behav Immun       Date:  2011-01-24       Impact factor: 7.217

2.  Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection.

Authors:  Ching-Yi Tsai; Zhuting Hu; Weijun Zhang; Edward J Usherwood
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

3.  Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.

Authors:  Costanza Casiraghi; Ana Citlali Márquez; Iryna Shanina; Marc Steven Horwitz
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

4.  The unique immunological and microbial aspects of pregnancy.

Authors:  Gil Mor; Paulomi Aldo; Ayesha B Alvero
Journal:  Nat Rev Immunol       Date:  2017-06-19       Impact factor: 53.106

Review 5.  Viral infections during pregnancy.

Authors:  Michelle Silasi; Ingrid Cardenas; Ja-Young Kwon; Karen Racicot; Paula Aldo; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2015-01-13       Impact factor: 3.886

6.  Effects of Sleep Fragmentation and Chronic Latent Viral Infection on Behavior and Inflammation in Mice.

Authors:  Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

Review 7.  Trophoblast-microbiome interaction: a new paradigm on immune regulation.

Authors:  Gil Mor; Ja-Young Kwon
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

Review 8.  Understanding the complexity of the immune system during pregnancy.

Authors:  Karen Racicot; Ja-Young Kwon; Paulomi Aldo; Michelle Silasi; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2014-07-04       Impact factor: 3.886

9.  Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivo.

Authors:  Aurore Vidy; Torsten Sacher; Heiko Adler; Stefan Jordan; Ulrich H Koszinowski; Zsolt Ruzsics
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

10.  CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection.

Authors:  Mario Cocco; Cristiana Bellan; Roxane Tussiwand; Davide Corti; Elisabetta Traggiai; Stefano Lazzi; Susanna Mannucci; Lucio Bronz; Nazzareno Palummo; Chiara Ginanneschi; Piero Tosi; Antonio Lanzavecchia; Markus G Manz; Lorenzo Leoncini
Journal:  Am J Pathol       Date:  2008-10-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.